Corona test obligation: employers criticize Merkel’s testing law



[ad_1]

A corona test obligation for businesses is approaching, but the economy is against it and is increasingly on a confrontational course with the federal government. Employer President Rainer Dulger said private companies had greatly expanded their testing efforts: Anyone who constantly threatens legal regulation does not recognize this commitment. “A trial law does not create more protection, but more bureaucracy, more costs, less initiative and a lot of unanswered legal and organizational questions,” he said.

The business representative responded to the statements of Chancellor Angela Merkel. The CDU politician criticized the slow implementation of voluntary commitments in the economy Sunday night on the ARD program “Anne Will.” Accordingly, any employee who is not in the central office must be tested twice a week, if possible, and this must also be certified. He is under the impression that this will not be implemented across the board, Merkel said. Testing should probably be mandatory in factories.

The president of the German Federation of Trade Unions, Reiner Hoffmann, supports Merkel’s direction. “Commitment alone is not enough,” he said. “Too many employers still refuse to fulfill their responsibilities. Trial offers must be mandatory and costs must be borne by employers. “Any personal contact that can be avoided helps reduce the rate of infection.

A survey by the German Chamber of Commerce and Industry in mid-March showed that 19 percent of companies offer regular testing and 28 percent of companies plan to do so soon. At the time, half of the companies had no concrete plans for a test strategy; however, according to the survey, 23 percent of companies worked exclusively at the head office. In addition, many companies are blocked, for example, in the catering industry.

In the business world, there is also some reference to delivery difficulties. It is said that there are not enough test kits available. However, the federal government emphasizes that there are now enough rapid tests on the market.


[ad_2]